Cargando…

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management

Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Salama, Lavinia, Pastor, Elizabeth R., Stone, Tyler, Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554840/
https://www.ncbi.nlm.nih.gov/pubmed/32932737
http://dx.doi.org/10.3390/biomedicines8090347
_version_ 1783593867611734016
author Salama, Lavinia
Pastor, Elizabeth R.
Stone, Tyler
Mousa, Shaker A.
author_facet Salama, Lavinia
Pastor, Elizabeth R.
Stone, Tyler
Mousa, Shaker A.
author_sort Salama, Lavinia
collection PubMed
description Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technology has achieved considerable progress in the oncology field in recent years. Most chemotherapeutic agents are not specific to the cancer cells they are intended to treat, and they can harm healthy cells, leading to numerous adverse effects. Due to this non-specific targeting, it is not feasible to administer high doses that may harm healthy cells. Moreover, low doses can cause cancer cells to acquire resistance, thus making them hard to kill. A solution that could potentially enhance drug targeting and delivery lies in understanding the complexity of nanotechnology. Engineering pharmaceutical and natural products into nano-products can enhance the diagnosis and treatment of cancer. Novel nano-formulations such as liposomes, polymeric micelles, dendrimers, quantum dots, nano-suspensions, and gold nanoparticles have been shown to enhance the delivery of drugs. Improved delivery of chemotherapeutic agents targets cancer cells rather than healthy cells, thereby preventing undesirable side effects and decreasing chemotherapeutic drug resistance. Nanotechnology has also revolutionized cancer diagnosis by using nanotechnology-based imaging contrast agents that can specifically target and therefore enhance tumor detection. In addition to the delivery of drugs, nanotechnology can be used to deliver nutraceuticals like phytochemicals that have multiple properties, such as antioxidant activity, that protect cells from oxidative damage and reduce the risk of cancer. There have been multiple advancements and implications for the use of nanotechnology to enhance the delivery of both pharmaceutical and nutraceutical products in cancer prevention, diagnosis, and treatment.
format Online
Article
Text
id pubmed-7554840
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75548402020-10-14 Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management Salama, Lavinia Pastor, Elizabeth R. Stone, Tyler Mousa, Shaker A. Biomedicines Review Nanotechnology is the science of nanoscale, which is the scale of nanometers or one billionth of a meter. Nanotechnology encompasses a broad range of technologies, materials, and manufacturing processes that are used to design and/or enhance many products, including medicinal products. This technology has achieved considerable progress in the oncology field in recent years. Most chemotherapeutic agents are not specific to the cancer cells they are intended to treat, and they can harm healthy cells, leading to numerous adverse effects. Due to this non-specific targeting, it is not feasible to administer high doses that may harm healthy cells. Moreover, low doses can cause cancer cells to acquire resistance, thus making them hard to kill. A solution that could potentially enhance drug targeting and delivery lies in understanding the complexity of nanotechnology. Engineering pharmaceutical and natural products into nano-products can enhance the diagnosis and treatment of cancer. Novel nano-formulations such as liposomes, polymeric micelles, dendrimers, quantum dots, nano-suspensions, and gold nanoparticles have been shown to enhance the delivery of drugs. Improved delivery of chemotherapeutic agents targets cancer cells rather than healthy cells, thereby preventing undesirable side effects and decreasing chemotherapeutic drug resistance. Nanotechnology has also revolutionized cancer diagnosis by using nanotechnology-based imaging contrast agents that can specifically target and therefore enhance tumor detection. In addition to the delivery of drugs, nanotechnology can be used to deliver nutraceuticals like phytochemicals that have multiple properties, such as antioxidant activity, that protect cells from oxidative damage and reduce the risk of cancer. There have been multiple advancements and implications for the use of nanotechnology to enhance the delivery of both pharmaceutical and nutraceutical products in cancer prevention, diagnosis, and treatment. MDPI 2020-09-12 /pmc/articles/PMC7554840/ /pubmed/32932737 http://dx.doi.org/10.3390/biomedicines8090347 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Salama, Lavinia
Pastor, Elizabeth R.
Stone, Tyler
Mousa, Shaker A.
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title_full Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title_fullStr Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title_full_unstemmed Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title_short Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
title_sort emerging nanopharmaceuticals and nanonutraceuticals in cancer management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554840/
https://www.ncbi.nlm.nih.gov/pubmed/32932737
http://dx.doi.org/10.3390/biomedicines8090347
work_keys_str_mv AT salamalavinia emergingnanopharmaceuticalsandnanonutraceuticalsincancermanagement
AT pastorelizabethr emergingnanopharmaceuticalsandnanonutraceuticalsincancermanagement
AT stonetyler emergingnanopharmaceuticalsandnanonutraceuticalsincancermanagement
AT mousashakera emergingnanopharmaceuticalsandnanonutraceuticalsincancermanagement